āK
t
Maya Martinez-Davis, President, US of GSK plc, acquired 129.152 notional American Depositary Shares (ADS) within her GSK Executive Supplemental Savings Plan account. This transaction took place on March 13, 2026, on the New York Stock Exchange (XNYS) at a price of $53.3900 per ADS.
| Date | 17 Mar 2026 |
| Time | 15:30:01 |
| Category | Director/PDMR dealings |
| ID | 0152X |
GSK plc (the 'Company')
Transaction notification
ā
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Maya Martinez-Davis |
|||
|
b) |
Position/status |
President, US |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADS')
ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account.
|
|||
|
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
|
$53.3900 |
129.152 |
|
||
|
|
|
|
|
||
|
d) |
Aggregated information
|
N/A (single transaction) |
|||
|
Aggregated volume Price |
|
||||
|
e) |
Date of the transaction |
2026-03-13 |
|||
|
f) |
Place of the transaction
|
New York Stock Exchange (XNYS) |
|||
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG